Literature DB >> 25569709

Transformation of oligomers of lipidated peptide induced by change in pH.

Ying Wang1, Aleksey Lomakin, Sonoko Kanai, Rainer Alex, George B Benedek.   

Abstract

Oligomerization of lipidated peptides is of general scientific interest and is important in biomedical and pharmaceutical applications. We investigated the solution properties of a lipidated peptide, Liraglutide, which is one of the glucagon-like peptide-1 (GLP-1) agonists used for the treatment of type II diabetes. Liraglutide can serve as a model system for studying biophysical and biochemical properties of micelle-like self-assemblies of the lipidated peptides. Here, we report a transformation induced in Liraglutide oligomers by changing pH in the vicinity of pH 7. This fully reversible transformation is characterized by changes in the size and aggregation number of the oligomer and an associated change in the secondary structure of the constituent peptides. This transformation has quite slow kinetics: the equilibrium is reached in a course of several days. Interestingly, while the transformation is induced by changing pH, its kinetics is essentially independent of the final pH. We interpreted these findings using a model in which desorption of the monomer from the oligomer is the rate-limiting step in the transformation, and we determined the rate constant of the monomer desorption.

Entities:  

Keywords:  incretin; light scattering; micelle; oligomerization; peptide amphiphile; self-assembly

Mesh:

Substances:

Year:  2015        PMID: 25569709     DOI: 10.1021/mp500519s

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  15 in total

Review 1.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 2.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

Review 3.  Derivatization with fatty acids in peptide and protein drug discovery.

Authors:  Peter Kurtzhals; Søren Østergaard; Erica Nishimura; Thomas Kjeldsen
Journal:  Nat Rev Drug Discov       Date:  2022-08-24       Impact factor: 112.288

4.  Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.

Authors:  Therese S Salameh; Elizabeth M Rhea; Konrad Talbot; William A Banks
Journal:  Biochem Pharmacol       Date:  2020-08-02       Impact factor: 5.858

Review 5.  Battle of GLP-1 delivery technologies.

Authors:  Minzhi Yu; Mason M Benjamin; Santhanakrishnan Srinivasan; Emily E Morin; Ekaterina I Shishatskaya; Steven P Schwendeman; Anna Schwendeman
Journal:  Adv Drug Deliv Rev       Date:  2018-07-21       Impact factor: 15.470

6.  Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide.

Authors:  Angélique Gajahi Soudahome; Aurélie Catan; Pierre Giraud; Sandrine Assouan Kouao; Alexis Guerin-Dubourg; Xavier Debussche; Nathalie Le Moullec; Emmanuel Bourdon; Susana B Bravo; Beatriz Paradela-Dobarro; Ezequiel Álvarez; Olivier Meilhac; Philippe Rondeau; Joël Couprie
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

7.  Oligomerization of a Glucagon-like Peptide 1 Analog: Bridging Experiment and Simulations.

Authors:  Tine M Frederiksen; Pernille Sønderby; Line A Ryberg; Pernille Harris; Jens T Bukrinski; Anne M Scharff-Poulsen; Maria N Elf-Lind; Günther H Peters
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

8.  Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly.

Authors:  Myriam M Ouberai; Ana L Gomes Dos Santos; Sonja Kinna; Shimona Madalli; David C Hornigold; David Baker; Jacqueline Naylor; Laura Sheldrake; Dominic J Corkill; John Hood; Paolo Vicini; Shahid Uddin; Steven Bishop; Paul G Varley; Mark E Welland
Journal:  Nat Commun       Date:  2017-10-18       Impact factor: 14.919

Review 9.  Peptide hormones and lipopeptides: from self-assembly to therapeutic applications.

Authors:  J A Hutchinson; S Burholt; I W Hamley
Journal:  J Pept Sci       Date:  2017-01-27       Impact factor: 1.905

10.  Rational Development of Stable PYY3-36 Peptide Y2 Receptor Agonists.

Authors:  Christian Poulsen; Marie Østergaard Pedersen; Per-Olof Wahlund; Annika Sjölander; Jens Kaalby Thomsen; Kilian W Conde-Frieboes; Johan F Paulsson; Birgitte S Wulff; Søren Østergaard
Journal:  Pharm Res       Date:  2021-07-16       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.